课题基金 / 基金详情

IGF::OT::IGF Vascular Interventions/Innovations and Therapeutic Advances(VITA): A Phase 1 Study to Assess the Safety and Pharmacokinetics of GMI-1271 in Healthy Adult Subjects and Calf Vein DVT

IGF::OT::IGF Vascular Interventions/Innovations and Therapeutic Advances(VITA): A Phase 1 Study to Assess the Safety and Pharmacokinetics of GMI-1271 in Healthy Adult Subjects and Calf Vein DVT
IGF::OT::IGF 血管干预/创新和治疗进展 (VITA)：一项评估 GMI-1271 在健康成人受试者和小腿静脉 DVT 中的安全性和药代动力学的 1 期研究
批准号：
9004521
负责人：
COLLEEN VOLGER
金额：
$59.04万
依托单位：
UNIVERSITY OF MICHIGAN AT ANN ARBOR
依托单位国家：
美国
项目类别：
财政年份：
2013
资助国家：
美国
项目状态：
已结题
起止时间：
2013-11-15 至 2015-11-14
来源：
https://reporter.nih.gov/project-details/9004521
关键词：
AccountingAdultAdverse effectsBlood VesselsCase StudyCessation of lifeClinicalClinical ResearchContractsDeep Vein ThrombosisDevelopmentDiagnosticDiseaseDrug KineticsFundingGoalsHemorrhageInterventionMedicalModalityNational Heart, Lung, and Blood InstitutePhasePulmonary EmbolismPulmonary HypertensionSafetyStagingSupport ContractsTherapeuticThromboembolismVascular DiseasesVeinsVenousinnovationmortalitynovelphase 1 studyproduct developmentprograms

项目摘要

项目成果

COLLEEN VOLGER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Vascular Interventions/Innovations and Therapeutic Advances (VITA) Program is a new translational initiative of the National Heart, Lung, and Blood Institute (NHLBI) that enables and accelerates the development of promising diagnostic and therapeutic modalities for unmet and underserved medical needs. The VITA Program provides contract support for early-stage translational development of product candidates in the fields of vascular disorders, thrombotic diseases, and pulmonary hypertension.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金